by admin_63069 | Oct 21, 2024 | Related Topics
As a community, we’re looking at better ways to improve outcomes, and one way to achieve that, potentially, is docetaxel chemotherapy.
by admin_63069 | Oct 14, 2024 | Related Topics
Patients with PSMA-positive metastatic castration-resistant prostate cancer can now be treated with Pluvicto, which may provide hope to an unmet need in this patient population.
by admin_63069 | Oct 7, 2024 | Related Topics
Recent article in Time magazine
by admin_63069 | Sep 30, 2024 | Related Topics
This report is a review of recent and emerging trends that promise to make radiation oncology for prostate cancer more efficient, effective, and patient-friendly.
by admin_63069 | Sep 23, 2024 | Related Topics
This could be a game changer in prostate cancer diagnosis.
by admin_63069 | Sep 16, 2024 | Related Topics
Following treatment with olaparib, 13 participants, including all 11 who had BRCA2 mutations, had a decrease in PSA of at least 50% — a sign that their cancers were receding.
